Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales

(2014) A Linton et al.   BRITISH JOURNAL OF CANCER

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival

(2014) Francine Baumann et al.   CARCINOGENESIS

Regulatory T cells in cancer immunotherapy

(2014) Hiroyoshi Nishikawa et al.   CURRENT OPINION IN IMMUNOLOGY

Immunomodulation in cancer

(2014) Joost PJJ Hegmans et al.   CURRENT OPINION IN PHARMACOLOGY

Tumor-Associated Macrophages: From Mechanisms to Therapy

(2014) Roy Noy et al.   IMMUNITY

Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4

(2014) James Badger Wing et al.   IMMUNITY

Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients

(2014) Pietro Bovolato et al.   Journal of Thoracic Oncology

Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

(2014) Ahmad A. Tarhini et al.   PLoS One

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

(2013) Luana Calabrò et al.   LANCET ONCOLOGY

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

(2012) Eva Ellebaek et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

New Roads Open Up for Implementing Immunotherapy in Mesothelioma

(2012) R. Cornelissen et al.   Clinical & Developmental Immunology

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission

(2011) Christina S. Chu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome

(2011) Yingzi Ge et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma

(2011) A. Nakas et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients

(2011) C. Alfaro et al.   JOURNAL OF IMMUNOLOGY

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

(2011) Giovanni L. Ceresoli et al.   LUNG CANCER

Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey

(2011) P.A. Zucali et al.   LUNG CANCER

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

(2011) Antonella Sistigu et al.   Seminars in Immunopathology

Immunotherapy response evaluation with 18F-FDG-PET in patients with advanced stage renal cell carcinoma

(2011) Rozemarie Gilles et al.   WORLD JOURNAL OF UROLOGY

Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma

(2010) Joost P. Hegmans et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A Phase I Trial of Repeated Intrapleural Adenoviral-mediated Interferon-β Gene Transfer for Mesothelioma and Metastatic Pleural Effusions

(2010) Daniel H Sterman et al.   MOLECULAR THERAPY